Identification and treatment of metabolic complications in pediatric obesity

Katie Larson Ode; Brigitte I. Frohnert; Brandon M. Nathan

doi:10.1007/s11154-009-9115-7

Identification and treatment of metabolic complications in pediatric obesity

Katie Larson Ode, Brigitte I. Frohnert, Brandon M. Nathan

Pediatric Endocrinology

Research output: Contribution to journal › Review article › peer-review

51 Scopus citations

Abstract

Metabolic consequences of obesity including insulin resistance, type 2 diabetes mellitus, hyperlipidemia, hypertension, polycystic ovarian syndrome, and non-alcoholic fatty liver infiltration are rapidly emerging in the pediatric population. Identifying effective strategies for identifying and treating these obesity related co-morbidities in children are crucial to the prevention of future cardiovascular disease and poor health outcomes. This review discusses the pathophysiologic connections between obesity, metabolic disease and cardiovascular risk. Current evidence and recommendations for screening and treatment for the metabolic consequences of pediatric obesity are reviewed.

Original language	English (US)
Pages (from-to)	167-188
Number of pages	22
Journal	Reviews in Endocrine and Metabolic Disorders
Volume	10
Issue number	3
DOIs	https://doi.org/10.1007/s11154-009-9115-7
State	Published - Sep 2009

Keywords

Fatty liver disease
Insulin resistance
Metabolic syndrome
Polycystic ovary disease
Type 2 diabetes mellitus

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1007/s11154-009-9115-7

Find It

Find It at U of M Libraries

Cite this

@article{2b97e18b9c3046568fcd773989642c8d,

title = "Identification and treatment of metabolic complications in pediatric obesity",

abstract = "Metabolic consequences of obesity including insulin resistance, type 2 diabetes mellitus, hyperlipidemia, hypertension, polycystic ovarian syndrome, and non-alcoholic fatty liver infiltration are rapidly emerging in the pediatric population. Identifying effective strategies for identifying and treating these obesity related co-morbidities in children are crucial to the prevention of future cardiovascular disease and poor health outcomes. This review discusses the pathophysiologic connections between obesity, metabolic disease and cardiovascular risk. Current evidence and recommendations for screening and treatment for the metabolic consequences of pediatric obesity are reviewed.",

keywords = "Fatty liver disease, Insulin resistance, Metabolic syndrome, Polycystic ovary disease, Type 2 diabetes mellitus",

author = "Ode, {Katie Larson} and Frohnert, {Brigitte I.} and Nathan, {Brandon M.}",

year = "2009",

month = sep,

doi = "10.1007/s11154-009-9115-7",

language = "English (US)",

volume = "10",

pages = "167--188",

journal = "Reviews in Endocrine and Metabolic Disorders",

issn = "1389-9155",

publisher = "Springer Netherlands",

number = "3",

}

TY - JOUR

T1 - Identification and treatment of metabolic complications in pediatric obesity

AU - Ode, Katie Larson

AU - Frohnert, Brigitte I.

AU - Nathan, Brandon M.

PY - 2009/9

Y1 - 2009/9

N2 - Metabolic consequences of obesity including insulin resistance, type 2 diabetes mellitus, hyperlipidemia, hypertension, polycystic ovarian syndrome, and non-alcoholic fatty liver infiltration are rapidly emerging in the pediatric population. Identifying effective strategies for identifying and treating these obesity related co-morbidities in children are crucial to the prevention of future cardiovascular disease and poor health outcomes. This review discusses the pathophysiologic connections between obesity, metabolic disease and cardiovascular risk. Current evidence and recommendations for screening and treatment for the metabolic consequences of pediatric obesity are reviewed.

AB - Metabolic consequences of obesity including insulin resistance, type 2 diabetes mellitus, hyperlipidemia, hypertension, polycystic ovarian syndrome, and non-alcoholic fatty liver infiltration are rapidly emerging in the pediatric population. Identifying effective strategies for identifying and treating these obesity related co-morbidities in children are crucial to the prevention of future cardiovascular disease and poor health outcomes. This review discusses the pathophysiologic connections between obesity, metabolic disease and cardiovascular risk. Current evidence and recommendations for screening and treatment for the metabolic consequences of pediatric obesity are reviewed.

KW - Fatty liver disease

KW - Insulin resistance

KW - Metabolic syndrome

KW - Polycystic ovary disease

KW - Type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=70350200840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350200840&partnerID=8YFLogxK

U2 - 10.1007/s11154-009-9115-7

DO - 10.1007/s11154-009-9115-7

M3 - Review article

C2 - 19809879

AN - SCOPUS:70350200840

SN - 1389-9155

VL - 10

SP - 167

EP - 188

JO - Reviews in Endocrine and Metabolic Disorders

JF - Reviews in Endocrine and Metabolic Disorders

IS - 3

ER -

Identification and treatment of metabolic complications in pediatric obesity

Abstract

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this